Search

Your search keyword '"MESH : Depression"' showing total 10 results
Start Over Descriptor "MESH : Depression"
10 results on '"MESH : Depression"'

1. Incidence, Medical and Socio-Behavioural Predictors of Psychiatric Events in An 11-Year Follow-Up of HIV-Infected Patients on Antiretroviral Therapy

Author

Protopopescu, Camelia, Raffi, François, Brunet-François, Cécile, Salmon, Dominique, Verdon, Renaud, Reboud, Philippe, Carrieri, Maria Patrizia, Leport, Catherine, Spire, Bruno, Michel, Laurent, Michelet, Christian, Aix Marseille Université (AMU), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU), Maladies infectieuses et tropicales, Service de médecine interne et centre de référence des maladies rares [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Maladies Infectieuses et Tropicales [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques (U738 / UMR_S738), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Troubles du comportement alimentaire de l'adolescent (UMR_S 669), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Sud - Paris 11 (UP11), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), APROCO-COPILOTE (ANRS CO8) Study Group, Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Sud - Paris 11 (UP11)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Cochin [AP-HP]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Modèles et méthodes de l'évaluation thérapeutique des maladies chroniques, Aix Marseille Université ( AMU ), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale ( SESSTIM - U912 INSERM - AMU - IRD ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut de Recherche pour le Développement ( IRD ) -Aix Marseille Université ( AMU ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Service des maladies infectieuses et tropicales, CHU Caen, Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Troubles du comportement alimentaire de l'adolescent ( UMR_S 669 ), Université Paris-Sud - Paris 11 ( UP11 ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut de recherche, santé, environnement et travail ( Irset ), Université d'Angers ( UA ) -Université de Rennes 1 ( UR1 ), and Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -École des Hautes Études en Santé Publique [EHESP] ( EHESP ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ) -Université des Antilles ( UA )

Subjects
Male, MESH: CD4 Lymphocyte Count, Epidemiology, HIV Infections, MESH : Viral Load, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Surveys and Questionnaires, Immunopathology, Hiv infected patients, Pharmacology (medical), Longitudinal Studies, MESH: Incidence, MESH: Treatment Outcome, MESH: Middle Aged, Depression, MESH: HIV, Incidence, MESH : HIV Protease Inhibitors, MESH: Follow-Up Studies, MESH: HIV Infections, MESH : Incidence, 3. Good health, Suicide, [ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Drug Therapy, Combination, Viral disease, Infection, 0305 other medical science, MESH: Social Behavior, medicine.medical_specialty, 03 medical and health sciences, MESH : HIV Infections, Humans, MESH : Middle Aged, Antiviral, Social Behavior, Pharmacology, MESH: Humans, MESH: Questionnaires, MESH : Humans, MESH : Follow-Up Studies, MESH: Adult, MESH : Proportional Hazards Models, medicine.disease, Antiretroviral agent, MESH: Female, Immune deficiency, MESH : Social Behavior, MESH : HIV, MESH: Proportional Hazards Models, Risk Factors, MESH : Depression, MESH: Risk Factors, MESH : Female, 030212 general & internal medicine, MESH: Longitudinal Studies, MESH : Longitudinal Studies, MESH : Suicide, Incidence (epidemiology), MESH : Questionnaires, Middle Aged, Viral Load, MESH : Adult, MESH : Risk Factors, AIDS, Treatment Outcome, Infectious Diseases, Female, France, MESH: Viral Load, Adult, MESH: Depression, MESH : Male, MESH : Treatment Outcome, Acquired immunodeficiency syndrome (AIDS), MESH : CD4 Lymphocyte Count, medicine, Chemotherapy, MESH : France, Psychiatry, Proportional Hazards Models, MESH: HIV Protease Inhibitors, 030505 public health, Potential risk, business.industry, MESH : Drug Therapy, Combination, HIV, HIV Protease Inhibitors, Antiretroviral therapy, MESH: Male, CD4 Lymphocyte Count, Treatment, MESH: France, MESH: Drug Therapy, Combination, MESH: Suicide, Predictive factor, business, Follow-Up Studies
Abstract

Background Psychiatric disorders are relatively common among HIV-infected patients. However, there are few studies about their potential risk factors. This analysis aimed to measure the incidence of severe psychiatric events (PE) among patients receiving combination antiretroviral therapy (cART) of the French APROCO-COPILOTE (ANRS CO8) cohort, and to identify the medical and socio-behavioural correlates of their first episode of depression, suicide or suicide attempt (D/S/SA). Methods APROCO-COPILOTE is a cohort of patients started on a protease inhibitor regimen between 1997 and 1999, with prospective medical standardized records and self-administered questionnaires collecting socio-demographic and socio-behavioural data. This analysis included all 11-year follow-up visits for 1,095 patients having completed baseline self-administered questionnaires. A proportional hazard Cox model was used to identify the correlates of a first D/S/SA event. Results The overall prevalence of severe PE remained low: 50 patients experienced 67 events (incidence rate [95% CI] =1.04 [0.82, 1.32] per 100 person-years). Depression ( n=16), suicides ( n=5) and suicide attempts ( n=14) were the most frequently diagnosed PE (0.54 [0.39, 0.76] per 100 person-years) among 25 patients. Multivariate results showed that unemployment, unstable housing, detectable viral load and smoking more than 20 cigarettes/day were independently associated with D/S/SA. Conclusions Although the incidence of severe PE remained relatively low among the patients of APROCO-COPILOTE cohort, this study's results underline a clinically important problem in HIV-infected patients receiving cART. Furthermore, our findings not only emphasize the importance of comprehensive care, especially for socially vulnerable patients, but may also help future studies designed to assess the effectiveness of interventions in reducing the risk of PE during cART.

Published
2012
Full Text
View/download PDF

2. Efficacy of Tube Feeding in Binge-Eating/Vomiting Patients

Author

Marie-Claude Brindisi, Daniel Rigaud, Anne Roblot, Bruno Vergès, Véronique Brayer, Centre des Sciences du Goût et de l'Alimentation [Dijon] (CSGA), Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique (CNRS), Service d'endocrinologie et nutrition, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre des Sciences du Goût et de l'Alimentation [Dijon] ( CSGA ), Institut National de la Recherche Agronomique ( INRA ) -Université de Bourgogne ( UB ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique ( CNRS ), and Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon )

Subjects
Pediatrics, Hamilton Anxiety Rating Scale, [ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition, medicine.medical_treatment, Medicine (miscellaneous), Anxiety, Anorexia nervosa, law.invention, MESH : Anxiety, Randomized controlled trial, MESH : Depression, MESH: Vomiting, law, MESH : Vomiting, Bulimia, MESH : Muscle, Skeletal, MESH: Treatment Outcome, media_common, MESH: Muscle, Skeletal, Nutrition and Dietetics, MESH : Bulimia Nervosa, Depression, Bulimia nervosa, Body Fluid Compartments, MESH : Adult, Cognitive behavioral therapy, Eating disorders, Treatment Outcome, MESH: Young Adult, MESH : Cognitive Therapy, MESH : Bulimia, Adult, MESH: Enteral Nutrition, medicine.medical_specialty, MESH: Depression, Vomiting, media_common.quotation_subject, MESH : Young Adult, MESH : Treatment Outcome, behavioral disciplines and activities, Young Adult, Enteral Nutrition, MESH: Body Fluid Compartments, mental disorders, medicine, Humans, MESH : Body Fluid Compartments, MESH: Bulimia, Bulimia Nervosa, Muscle, Skeletal, MESH: Humans, Cognitive Behavioral Therapy, MESH: Anxiety, business.industry, MESH : Humans, MESH: Biological Markers, Beck Depression Inventory, MESH: Quality of Life, MESH: Adult, MESH : Quality of Life, Abstinence, medicine.disease, MESH: Cognitive Therapy, Surgery, MESH : Biological Markers, MESH : Enteral Nutrition, Quality of Life, business, MESH: Bulimia Nervosa, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, Biomarkers
Abstract

International audience; BACKGROUND: In many binge-eating/vomiting patients, abstinence could not be obtained from classical treatments. Since the authors showed that tube feeding (TF) reduced such episodes in anorexia nervosa (AN)-hospitalized patients, they carried out a randomized trial on the efficacy of TF plus cognitive behavioral therapy (CBT) vs CBT alone in AN and bulimia nervosa adult outpatients. METHODS: The authors randomly assigned 103 ambulatory patients to receive 16 sessions of CBT alone (n = 51) or CBT plus 2 months of TF (n = 52). The main goal was abstinence of binge-eating/vomiting episodes. Other criteria were gains in fat-free mass and muscle mass improvements in nutrition markers, and quality of life (SF-36 Health Survey), depression (Beck Depression Inventory), and anxiety (Hamilton Anxiety Rating Scale) scores. Evaluations were performed at 1, 2 (end of treatment), 5, 8, and 14 months (analysis of variance). RESULTS: TF patients were rapidly and more frequently abstinent at the end of treatment (2 months) than the CBT patients: 81% vs 29% (P < .001). Fat-free mass, biological markers, depressive state (-58% vs -26%), anxiety (-48% vs -15%), and quality of life (+42% vs +13%) were more improved in the TF group than in the CBT group (P < .05). One year later, more TF patients remained abstinent (68% vs 27%, P = .02); they were less anxious, were less depressed, and had better quality of life than the CBT patients (P < .05). CONCLUSION: TF combined with CBT offered better results than CBT alone.

Published
2011
Full Text
View/download PDF

3. Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort

Author

Bacconnier , Ludovic, Rincheval , Nathalie, Flipo , René-Marc, Goupille , Philippe, Daures , Jean-Pierre, Boulenger , Jean-Philippe, Combe , Bernard, Saraux , Alain, Institut de Génétique Moléculaire de Montpellier ( IGMM ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - IURC, Université Montpellier 1 ( UM1 ) -Université de Montpellier ( UM ), Service de rhumatologie[Lille], Hôpital Roger Salengro-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Génétique, Immunothérapie, Chimie et Cancer ( GICC ), Université de Tours-Centre National de la Recherche Scientifique ( CNRS ), Département de psychiatrie adulte, Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital La Colombière, Neuropsychiatrie : recherche épidémiologique et clinique, Université Montpellier 1 ( UM1 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Département de Rhumatologie[Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie, Centre d'Investigation Clinique INSERM 1412 ( CIC 1412 - BREST ), Centre Hospitalier Régional Universitaire de Brest ( CHRU Brest ), Lymphocyte B et Auto-immunité ( LBAI ), Université de Brest ( UBO ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), CHRU Brest - Service de Rhumatologie ( CHU - BREST - Rhumato ), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Aide à la Décision pour une Médecine Personnalisé - Laboratoire de Biostatistique, Epidémiologie et Recherche Clinique - EA 2415 (AIDMP), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Génétique, immunothérapie, chimie et cancer (GICC), UMR 7292 CNRS [2012-2017] (GICC UMR 7292 CNRS), Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital La Colombière, Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie, Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lymphocyte B et Auto-immunité (LBAI), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), CHRU Brest - Service de Rhumatologie (CHU - BREST - Rhumato), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Université de Tours-Centre National de la Recherche Scientifique (CNRS), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), and Université de Brest (UBO)

Subjects
Longitudinal study, Time Factors, MESH : Prevalence, [SDV]Life Sciences [q-bio], early rheumatoid arthritis, MESH : Prospective Studies, MESH: Comorbidity, MESH: Logistic Models, Comorbidity, Anxiety, MESH : Early Diagnosis, Arthritis, Rheumatoid, Cohort Studies, Disability Evaluation, 0302 clinical medicine, MESH : Anxiety, psychological distress, MESH: Early Diagnosis, MESH : Depression, Surveys and Questionnaires, Prevalence, Medicine, Pharmacology (medical), MESH : Female, Longitudinal Studies, Prospective Studies, 030212 general & internal medicine, MESH: Longitudinal Studies, Prospective cohort study, MESH: Cohort Studies, MESH : Longitudinal Studies, MESH: Arthritis, Rheumatoid, MESH: Middle Aged, MESH: Disability Evaluation, MESH: Stress, Psychological, Middle Aged, MESH : Adult, 3. Good health, Psychological evaluation, Distress, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Cohort, depression, MESH : Comorbidity, Female, France, medicine.symptom, MESH : Surveys and Questionnaires, MESH : Time Factors, Adult, medicine.medical_specialty, MESH: Depression, MESH : Cohort Studies, MESH : Disability Evaluation, [ SDV.MHEP.RSOA ] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, 03 medical and health sciences, Rheumatology, Internal medicine, [ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology, Humans, Psychological testing, MESH : Middle Aged, MESH: Surveys and Questionnaires, MESH : France, MESH: Prevalence, 030203 arthritis & rheumatology, MESH: Humans, MESH: Anxiety, [ SDV ] Life Sciences [q-bio], business.industry, MESH: Time Factors, MESH : Humans, MESH: Adult, Odds ratio, HAQ, MESH: Prospective Studies, MESH: France, MESH : Stress, Psychological, Early Diagnosis, Logistic Models, MESH : Arthritis, Rheumatoid, Physical therapy, business, MESH: Female, Stress, Psychological, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, MESH : Logistic Models
Abstract

International audience; Objective. RA is a chronic disease with frequent psychological co-morbidities, of which depression and anxiety are two common manifestations. We aimed to identify predictive factors of psychological distress in a large prospective cohort of very early RA patients.Methods. ESPOIR (Etude et Suivi des Polyarthrites Indifférenciées Récentes) is a multicentre, longitudinal and prospective cohort study of patients with early arthritis (

Published
2015
Full Text
View/download PDF

4. Usefulness of a single-item measure of depression to predict mortality: the GAZEL prospective cohort study. : single-item of depression and mortality

Author

Thomas Lefèvre, Aline Dugravot, Hermann Nabi, Marie Zins, Silvia Stringhini, Cédric Lemogne, Silla M. Consoli, Marcel Goldberg, Archana Singh-Manoux, Laboratoire de Traitement de l'Information Medicale ( LaTIM ), Université européenne de Bretagne ( UEB ) -Télécom Bretagne-Centre Hospitalier Régional Universitaire de Brest ( CHRU Brest ) -Université de Brest ( UBO ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut Mines-Télécom [Paris], Centre de recherche en épidémiologie et santé des populations ( CESP ), Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Department of Epidemiology and Public Health, University College of London [London] ( UCL ), Centre de Gérontologie, Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Sainte-Périne-Rossini-Chardon Lagache, Université Paris Descartes - Paris 5 ( UPD5 ), Service Universitaire de Psychiatrie de l'Adulte et du sujet âgé, Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpitaux Universitaires Paris-Ouest (HUPO), Centre Emotion, Centre National de la Recherche Scientifique ( CNRS ) -CHU Pitié-Salpêtrière [APHP]-Université Pierre et Marie Curie - Paris 6 ( UPMC ), The GAZEL cohort study was funded by EDF-GDF and INSERM, and received grants from the Cohortes Santé TGIR Program. ASM is supported by a EUYRI award from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196, and R01AG034454).

Subjects
Male, Gerontology, Health Behavior, MESH : Prospective Studies, France/epidemiology, 0302 clinical medicine, Risk Factors, MESH : Depression, Cause of Death, Surveys and Questionnaires, Epidemiology, MESH : Socioeconomic Factors, MESH : Female, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Depression (differential diagnoses), Cause of death, MESH : Questionnaires, [ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie, Middle Aged, MESH : Adult, MESH : Risk Factors, 3. Good health, Mental Health, Predictive value of tests, Cohort, depression, single-item, Female, France, MESH : Psychiatric Status Rating Scales, Adult, medicine.medical_specialty, MESH : Male, 03 medical and health sciences, Predictive Value of Tests, Internal medicine, medicine, Humans, MESH : Middle Aged, MESH : Predictive Value of Tests, Risk factor, MESH : Health Behavior, MESH : France, Proportional Hazards Models, MESH : Cause of Death, Psychiatric Status Rating Scales, Proportional hazards model, business.industry, Depression/complications/diagnosis/mortality, MESH : Humans, Public Health, Environmental and Occupational Health, MESH : Follow-Up Studies, MESH : Proportional Hazards Models, mortality, 030227 psychiatry, Socioeconomic Factors, business, Follow-Up Studies
Abstract

International audience; BACKGROUND: It remains unknown whether short measures of depression perform as well as long measures in predicting adverse outcomes such as mortality. The present study aims to examine the predictive value of a single-item measure of depression for mortality. METHODS: A total of 14,185 participants of the GAZEL cohort completed the 20-item Center-for-Epidemiologic-Studies-Depression (CES-D) scale in 1996. One of these items (I felt depressed) was used as a single-item measure of depression. All-cause mortality data were available until 30 September 2009, a mean follow-up period of 12.7 years with a total of 650 deaths. RESULTS: In Cox regression model adjusted for baseline socio-demographic characteristics, a one-unit increase in the single-item score (range 0-3) was associated with a 25% higher risk of all-cause mortality (95% CI: 13-37%, P

Published
2012
Full Text
View/download PDF

5. Prédicteurs de qualité de vie à long terme dans le cancer du sein

Author

Brunault , Paul, Toledano , Alain, Aguerre , Colette, Suzanne , Isabelle, Garaud , Pascal, Trzepidur-Edom , Magdalena, Calais , Gilles, Camus , Vincent, Clinique Psychiatrique Universitaire [Tours], CHRU Tours, Oncologie Radiothérapie, Clinique Hartmann - Hôpital américain de paris, Psychologie des âges de la vie ( PAVeA ), Université de Tours, Clinique d'Oncologie et de Radiothérapie [Tours] ( CORAD ), Hôpital Bretonneau-CHRU Tours, Imagerie et cerveau, Université de Tours-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Psychologie des âges de la vie et adaptation (PAVeA), Université de Tours (UT), Clinique d'Oncologie et de Radiothérapie [Tours] (CORAD), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Imagerie et cerveau (iBrain - Inserm U1253 - UNIV Tours ), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
MESH : Esthetics, MESH: Radiotherapy, MESH: breast cancer, MESH: Depression, MESH : Survivors, [ SDV.MHEP.PSM ] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, MESH : Analysis of Variance, MESH : Breast Neoplasms, MESH : Anxiety, MESH: long-term survivors, MESH : long-term survivors, MESH : Depression, MESH: Analysis of Variance, MESH : Female, MESH : Middle Aged, MESH : France, MESH: Chemoradiotherapy, MESH: Survivors, MESH: Humans, MESH: Middle Aged, MESH: Anxiety, MESH : Radiotherapy, MESH : Humans, MESH: Quality of Life, MESH : Follow-Up Studies, MESH: Follow-Up Studies, MESH : Quality of Life, MESH : Chemoradiotherapy, humanities, MESH : breast cancer, MESH: France, [SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health, MESH: Esthetics, MESH: Female, MESH: Breast Neoplasms
Abstract

International audience; INTRODUCTION: This study aimed to assess the impact of late treatment toxicity (especially radiotherapy toxicity), chemoradiotherapy treatment type (concurrent or sequential), depression and anxiety on overall, physical and emotional quality of life (QoL) in long-term breast cancer survivors. Method. We assessed 117 patients (mean follow-up since the end of treatment = 8.1 years) for late radiotherapy toxicity (LENT-SOMA scale), patient and doctor ratings of breast cosmetic outcomes, QoL (EORTC QLQ-C30), depression and anxiety (Hospital and Anxiety Depression scale). RESULTS: In univariate analyses, factors associated with significantly decreased QoL were: use of sequential treatment and decreased overall QoL (P = 0.002) and emotional QoL (P = 0.02) ; few radiotherapy late toxicity symptoms (pain and decreased physical QoL, P = 0.01 ; fibrosis and decreased emotional QoL, P = 0.04) ; probable depression or probable anxiety and decreased overall, physical and emotional QoL (P ≤ 0.005). In multivariate analyses, probable depression and probable anxiety were the most stronger predictors for decreased QoL in the overall, physical and emotional domains (P ≤ 0.02). CONCLUSION: Improving screening for and treatment of depression and anxiety might improve QoL in long-term breast cancer survivors.

Published
2012
Full Text
View/download PDF

6. Outcome in AN adult patients: a 13-year follow-up in 484 patients

Author

V. Reveillard, C Bizeul, Bruno Vergès, Daniel Rigaud, H Pennacchio, Centre des Sciences du Goût et de l'Alimentation [Dijon] (CSGA), Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique (CNRS), Service d'endocrinologie et nutrition, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre des Sciences du Goût et de l'Alimentation [Dijon] ( CSGA ), Institut National de la Recherche Agronomique ( INRA ) -Université de Bourgogne ( UB ) -AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Centre National de la Recherche Scientifique ( CNRS ), and Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand ( CHU Dijon )

Subjects
Male, Anorexia Nervosa, MESH : Recurrence, [ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition, Endocrinology, Diabetes and Metabolism, Anxiety, medicine.disease_cause, Anorexia nervosa, Outcome (game theory), Body Mass Index, MESH : Anxiety, Endocrinology, Recurrence, Risk Factors, MESH : Depression, MESH: Risk Factors, Surveys and Questionnaires, MESH : Female, Menstruation Disturbances, media_common, MESH: Treatment Outcome, MESH : Prognosis, Depression, Bulimia nervosa, Mortality rate, MESH : Questionnaires, General Medicine, Perfectionism (psychology), MESH: Follow-Up Studies, MESH : Adult, Prognosis, MESH : Risk Factors, Treatment Outcome, MESH : Anorexia Nervosa, Female, medicine.symptom, MESH: Anorexia Nervosa, Adult, medicine.medical_specialty, MESH: Depression, MESH : Male, media_common.quotation_subject, MESH : Treatment Outcome, MESH: Prognosis, MESH: Body Mass Index, Internal medicine, Internal Medicine, medicine, Humans, Personality, MESH: Menstruation Disturbances, Psychiatry, MESH: Humans, MESH: Anxiety, business.industry, MESH: Questionnaires, MESH : Humans, MESH : Follow-Up Studies, MESH: Adult, MESH : Menstruation Disturbances, medicine.disease, MESH: Male, MESH: Recurrence, MESH : Body Mass Index, business, Body mass index, MESH: Female, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, Follow-Up Studies
Abstract

International audience; BACKGROUND: To study the long-term prognosis of anorexia nervosa (AN), 484 adult AN patients were followed on a mean duration of 13 years. RESULTS: The mortality rate was 1.2%. Eight factors were linked to the lack of recovery at 2 years: low BMI at discharge, low energy and fat intakes, high drive for excessive exercising, high score for perfectionism, for interpersonal distrust and for anxiety, use of tube-feeding and adhesion to treatment (P18.5 kg/m(2); and having no physical hyperactivity. The recovery rate increased with the elapsing of relapse-free time (P=0.02). After a 13.5-year follow-up, 292 out of the 484 patients were recovered (60.3%), 25.8% had a relatively good outcome, 6.4% a bad outcome and 6.4% a severe outcome. Very few factors were identified as predictors of a good outcome (binge-eating/purging subtype, personality disorder).

Published
2011
Full Text
View/download PDF

7. Perceptions of a 24-hour visiting policy in the intensive care unit

Author

Ghylaine Bretteville, Maité Garrouste-Orgeas, Jean Carlet, Alexis Tabah, Jean-François Timsit, Benoit Misset, François Philippart, Aude Verdavainne, Frédérique Diaw, Vincent Willems, Medical-Surgical ICU, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Hôpital Saint Joseph, INSERM U823, équipe 11 (Epidémiologie des cancers et des affections graves), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) - Université Paris Descartes - Paris 5 (UPD5) - Hôpital Saint Joseph, Université Joseph Fourier - Grenoble 1 (UJF) - CHU Grenoble - EFS - Institut National de la Santé et de la Recherche Médicale (INSERM) - Université Joseph Fourier - Grenoble 1 (UJF) - CHU Grenoble - EFS - Institut National de la Santé et de la Recherche Médicale (INSERM), and Vesin, Aurélien

Subjects
Male, Time Factors, MESH : Prevalence, MESH : Aged, MESH : Professional-Family Relations, MESH : Prospective Studies, Anxiety, MESH: Health Care Surveys, Critical Care and Intensive Care Medicine, Hospital Anxiety and Depression Scale, law.invention, Cohort Studies, 0302 clinical medicine, MESH : Anxiety, Professional-Family Relations, law, MESH : Visitors to Patients, MESH : Depression, Prevalence, MESH : Female, Prospective Studies, 030212 general & internal medicine, Simplified Acute Physiology Score, MESH: Cohort Studies, MESH: Aged, Depression, MESH: Paris, MESH : Paris, Intensive care unit, Organizational Policy, 3. Good health, Intensive Care Units, Cohort, Female, medicine.symptom, MESH : Organizational Policy, MESH : Intensive Care Units, MESH : Time Factors, MESH: Visitors to Patients, Paris, medicine.medical_specialty, MESH: Depression, Attitude of Health Personnel, MESH : Male, MESH: Attitude of Health Personnel, MESH : Cohort Studies, Family centered care, 03 medical and health sciences, Intensive care, Severity of illness, medicine, Humans, Family, MESH : Health Care Surveys, Psychiatry, MESH: Professional-Family Relations, MESH: Family, MESH: Prevalence, Aged, MESH: Humans, MESH: Anxiety, business.industry, MESH : Humans, MESH: Time Factors, 030208 emergency & critical care medicine, Visitors to Patients, MESH: Male, MESH: Prospective Studies, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Health Care Surveys, Emergency medicine, MESH : Family, MESH: Intensive Care Units, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Organizational Policy, business, MESH: Female, MESH : Attitude of Health Personnel
Abstract

International audience; OBJECTIVE: To examine perceptions by intensive care unit (ICU) workers of unrestricted visitation, to measure visiting times, and to determine prevalence of symptoms of anxiety and depression in family members. DESIGN: Observational, prospective, single-center cohort. SETTING: Medical-surgical ICU in a 460-bed tertiary-care hospital. PATIENTS: Two hundred nine consecutive patients hospitalized >3 days were studied over the first 5 ICU days. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Characteristics of patients (n = 209), families (n = 149), and ICU workers (n = 43) were collected. ICU workers reported their perceptions of unrestricted visitation, and family members completed the Hospital Anxiety and Depression Scale. Daily severity scores (Simplified Acute Physiology Score II and Logistic Organ Failure) and a workload score (Nine Equivalents of Nursing Manpower) were computed. Maximum median visit length was 120 mins per patient per day and occurred on days 4 and 5. No correlations were found among severity of illness, workload, and visit length. For 115 patients, both nurse and physician questionnaires were available; although several differences were noted, neither nurses nor physicians perceived open visitation as disrupting patient care. The median rating for delay in organizing care was "never" for physicians and "occasionally" for nurses. Nurses perceived more disorganization of care than physicians (p = .008). Compared with nurses, the physicians reported greater family trust (p = .0023), more family stress (p = .047), and greater unease when examining the patient (p = .02). The Hospital Anxiety and Depression Scale indicated symptoms of anxiety in 73 (49%) family members and depression in 44 (29.5%). CONCLUSIONS: The 24-hr visitation policy was perceived favorably by families. It induced only moderate discomfort among ICU workers, due to the potential for care interruption, in particular for nurses.

Published
2008
Full Text
View/download PDF

8. A communication strategy and brochure for relatives of patients dying in the ICU

Author

Fabienne Fieux, Gérald Choukroun, Fayçal Saidi, Jean Reignier, Christophe Adrie, Dany Goldgran-Toledano, Bruno Mégarbane, Benoît Schlemmer, Alexandre Lautrette, J. Randall Curtis, Sylvie Chevret, Michael Darmon, Didier Barnoud, Maité Garrouste-Orgeas, Gérard Bleichner, Richard Galliot, Frédéric Pochard, Georges Loubert, Mercé Jourdain, Elie Azoulay, Bertrand Souweine, Nancy Kentish Barnes, Luc Marie Joly, François Vincent, Hugues Georges, Cédric Bruel, Hôpital Saint-Louis, Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Rouen, Normandie Université (NU), Service de réanimation chirurgicale [Béclère], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Clinique de réanimation médicale, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-Hôpital Michallon, Hôpital d'Argenteuil, Hôpital Bichat - Claude Bernard, Hôpital Cochin [AP-HP], Shcool of medicine, University of Washington [Seattle], Hôpital de Pontoise, Medical-Surgical ICU, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Hôpital Saint Joseph, Hôpital de Tourcoing, Hôpital de Gonesse, Hôpital Salengro, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital Raymond Poincaré [AP-HP], Service de réanimation médicale, Hôpital les oudaries, Hôpital de Nemours, Unité de soins intensifs [Clermont Ferrand], CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Service de Réanimation Médico-Chirurgicale [Avicenne], Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP], Vesin, Aurélien, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ), Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Antoine Béclère, Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-Hôpital Albert Michallon, CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -Hôpital Saint Joseph, Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), AP-HP Hôpital Raymond Poincaré [Garches], CHU Clermont-Ferrand-Hôpital Gabriel Montpied, and Université Paris 13 ( UP13 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Avicenne

Subjects
Male, MESH : Aged, MESH : Professional-Family Relations, MESH : Pamphlets, Anxiety, Hospital Anxiety and Depression Scale, MESH : Stress Disorders, Post-Traumatic, law.invention, Stress Disorders, Post-Traumatic, 0302 clinical medicine, MESH : Anxiety, MESH: Aged, 80 and over, Randomized controlled trial, law, Interquartile range, Professional-Family Relations, MESH : Visitors to Patients, MESH : Depression, Medicine, MESH : Female, 030212 general & internal medicine, MESH: Terminally Ill, Depression (differential diagnoses), Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Depression, Communication, [ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie, General Medicine, Middle Aged, Intensive care unit, 3. Good health, Distress, Intensive Care Units, MESH: Stress Disorders, Post-Traumatic, Female, MESH: Communication, medicine.symptom, MESH : Communication, MESH : Intensive Care Units, MESH: Visitors to Patients, medicine.medical_specialty, MESH: Depression, MESH : Male, MESH : Terminally Ill, 03 medical and health sciences, MESH : Bereavement, Humans, Terminally Ill, Family, MESH : Middle Aged, Psychiatry, MESH : Aged, 80 and over, MESH: Professional-Family Relations, MESH: Family, Aged, MESH: Humans, MESH: Anxiety, business.industry, MESH : Humans, MESH: Bereavement, 030208 emergency & critical care medicine, Visitors to Patients, MESH: Male, Telephone interview, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Physical therapy, Pamphlets, MESH : Family, MESH: Intensive Care Units, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Pamphlets, MESH: Female, Bereavement
Abstract

International audience; BACKGROUND: There is a need for close communication with relatives of patients dying in the intensive care unit (ICU). We evaluated a format that included a proactive end-of-life conference and a brochure to see whether it could lessen the effects of bereavement. METHODS: Family members of 126 patients dying in 22 ICUs in France were randomly assigned to the intervention format or to the customary end-of-life conference. Participants were interviewed by telephone 90 days after the death with the use of the Impact of Event Scale (IES; scores range from 0, indicating no symptoms, to 75, indicating severe symptoms related to post-traumatic stress disorder [PTSD]) and the Hospital Anxiety and Depression Scale (HADS; subscale scores range from 0, indicating no distress, to 21, indicating maximum distress). RESULTS: Participants in the intervention group had longer conferences than those in the control group (median, 30 minutes [interquartile range, 19 to 45] vs. 20 minutes [interquartile range, 15 to 30]; P

Published
2007
Full Text
View/download PDF

9. Allergic rhinitis and its consequences on quality of sleep: An unexplored area

Author

Damien Leger, Céline Pribil, I. Chanal, Jean Bousquet, Francois Carat, Isabella Annesi-Maesano, Michel Rugina, Abdelkader El Hasnaoui, Sommeil-Vigilance-Fatigue et Santé Publique (VIFASOM - EA 7330), Université Paris Descartes - Paris 5 (UPD5)-Institut de Recherche Biomédicale des Armées [Brétigny-sur-Orge] (IRBA), Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherche en épidémiologie et biostatistique, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département pneumologie et addictologie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Arnaud de Villeneuve, Léger D, Annesi-Maesano I, Carat F, M Rugina, je Chanal, C Pribil, El Hasnaoui A, Bousquet J, Université Paris Descartes - Paris 5 (UPD5)-Institut de Recherche Biomédicale des Armées (IRBA), Sommeil-Vigilance-Fatigue et Santé Publique ( VIFASOM - EA 7330 ), Université Paris Descartes - Paris 5 ( UPD5 ), Epidémiologie des maladies infectieuses et modélisation ( ESIM ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris-Sud - Paris 11 ( UP11 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), and Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Arnaud de Villeneuve

Subjects
Male, MESH: Fatigue, Pediatrics, Allergy, MESH: Sexual Behavior, MESH: Asthma, Cross-sectional study, Anxiety, Severity of Illness Index, MESH : Anxiety, MESH : Cross-Sectional Studies, 0302 clinical medicine, MESH : Sexual Behavior, MESH : Depression, MESH: Hypnotics and Sedatives, Surveys and Questionnaires, Epidemiology, Hypnotics and Sedatives, MESH : Female, 030223 otorhinolaryngology, Fatigue, MESH: Sleep Disorders, Depression, Epworth Sleepiness Scale, Headache, MESH : Questionnaires, [ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie, MESH : Adult, MESH: Memory Disorders, Sleep in non-human animals, MESH: Case-Control Studies, 3. Good health, MESH : Snoring, MESH : Fatigue, MESH : Rhinitis, Allergic, Perennial, Anesthesia, MESH : Severity of Illness Index, Female, France, Adult, Sleep Wake Disorders, MESH : Case-Control Studies, medicine.medical_specialty, MESH: Snoring, Rhinitis, Allergic, Perennial, Alcohol Drinking, MESH: Depression, MESH : Male, MESH : Sex Factors, Sexual Behavior, MESH : Hypnotics and Sedatives, MESH : Asthma, 03 medical and health sciences, Sex Factors, MESH: Cross-Sectional Studies, MESH: Sex Factors, MESH: Severity of Illness Index, Severity of illness, MESH : Memory Disorders, Internal Medicine, medicine, Humans, MESH : France, Asthma, MESH : Headache, Memory Disorders, MESH: Humans, MESH: Rhinitis, Allergic, Perennial, MESH: Anxiety, business.industry, MESH: Questionnaires, MESH : Humans, Snoring, Case-control study, MESH: Headache, MESH: Adult, medicine.disease, MESH: Male, MESH: France, MESH : Alcohol Drinking, Cross-Sectional Studies, 030228 respiratory system, MESH : Sleep Disorders, Case-Control Studies, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Female, MESH: Alcohol Drinking
Abstract

International audience; BACKGROUND: Allergic rhinitis (AR) is common and has been shown to impair social life and sleep. Patients with severe symptoms may have more sleep disturbances than those with a mild form of the disease, but this has never been assessed using a validated tool. The objective of our study was to assess, in patients with AR, whether duration and severity of AR are associated with sleep impairment. METHODS: A nationwide controlled cross-sectional epidemiological study was carried out. A representative sample of 260 French ear, nose, and throat and allergy specialists enrolled 591 patients with AR of at least 1 year's duration. Sleep disorders, sleep quality, and AR were assessed using validated tools (Sleep Disorders Questionnaire, Epworth Sleepiness Scale, and Score for Allergic Rhinitis). The severity of AR was assessed using the Allergic Rhinitis and its Impact on Asthma classification. RESULTS: All dimensions of sleep were impaired by AR, particularly by the severe type. Sleep was significantly more impaired in patients with severe AR than in those with the mild type. The duration of AR (intermittent or persistent) had no effect on sleep. CONCLUSION: These data underline the close relationship between AR and sleep and highlight the need for clinicians, particularly general practitioners, to be attentive in this respect.

Published
2006
Full Text
View/download PDF

10. Fatigue and traumatic brain injury

Author

Belmont, A., Agar, N., Hugeron, C., Gallais, B., Azouvi, Philippe, Service de réeducation fonctionnelle [Raymond Poincaré], Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP Hôpital Raymond Poincaré [Garches], Physiologie et physiopathologie de la motricité chez l'homme, Université Pierre et Marie Curie - Paris 6 ( UPMC ) -IFR70-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Raymond Poincaré [AP-HP], and Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR70-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Sleep Wake Disorders, MESH: Fatigue, MESH: Humans, [SDV.BA.MVSA]Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health, MESH: Depression, MESH : Brain Injuries, Depression, MESH : Humans, MESH : Hypopituitarism, MESH: Hypopituitarism, Hypopituitarism, MESH : Fatigue, MESH : Depression, Brain Injuries, MESH : Sleep Disorders, MESH: Brain Injuries, Humans, [ SDV.BA.MVSA ] Life Sciences [q-bio]/Animal biology/Veterinary medicine and animal Health, Fatigue, MESH: Sleep Disorders
Abstract

International audience; Fatigue is frequent and disabling in patients with traumatic brain injury (TBI). Its mechanisms are complex and multifactorial. We performed a literature review of reports of the condition using the following key words: brain injury, depression, neuroendocrine dysfunction, and treatment. Five scales have been used to evaluate fatigue in TBI patients: the Fatigue Severity Scale, the visual analog scale (VAS) for fatigue, the Fatigue Impact Scale, the Barrow Neurological Institute (BNI) Fatigue Scale and the Cause of Fatigue (COF) Questionnaire. The BNI Fatigue Scale and the COF Questionnaire have been designed specifically for brain-injured patients. Fatigue is present in 43-73% of patients and is one of the first symptoms for 7% of them. Fatigue does not seem to be significantly related to injury severity not to time since injury. It can be related to mental effort necessary to overcome attention deficit and slowed processing ("coping hypothesis"). It can also be related to sleeping disorders and depression, although the relation between fatigue and depression are debated. Finally, fatigue can also be related to infraclinical pituitary insufficiency (growth hormone insufficiency, hypocorticism). To date, no published study of treatment of fatigue after TBI exists.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results